Zusammenfassung
Das akute Nierenversagen ist ein in der Intensivmedizin häufi ges Krankheitsbild. Es tritt in fast der Hälfte der Fälle im Rahmen eines Multiorganversagens oder eines septischen Schockgeschehens auf [52], wobei die Prognose trotz der Möglichkeit der Nierenersatztherapie von der Grunderkrankung abhängig ist. Darüber hinaus ist das akute Nierenversagen ein unabhängiger Risikofaktor für die Mortalität von Intensivpatienten [25], [30], [32].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
Literatur
Amanzadeh J, Reilly RF (2006) Hypophoshatemia: an evidencebased approach to its clinical consequences and management. Nat Clin Pract Nephrol 2:136–148
Angstwurm MW, Engelmann L, Zimmermann T, Lehmann C, Spes CH, Abel P, Strauß R, Meier-Hellmann A, Insel R, Radke J, Schüttler J, Gärtner R (2007) Selenium in Intensive Care (SIC): Results of a prospective randomized, placebo-controlled, multiple-center study in patients with severe systemic inflammatory response syndrome, sepsis and septic shock. Crit Care Med 35:118–126
Asif A, Epstein M (2004) Prevention of radiocontrast-induced nephropathy. Am J Kidney Dis 44:12–24
Bagshaw SM, Delaney A, Haase M, Ghali WA, Bellomo R (2007) Loop diuretics in the management of acute renal failure: a systematic review and meta-analysis. Crit Care Resusc 9:60–68
Bagshaw SM, Berthiaume LR, Delaney A, Bellomo R (2008) Continuous versus intermittent renal replacement therapy for critically ill patients with acute kidney injury: A meta-analysis. Crit Care Med 36:610–617
Bagshaw SM, Uchino S, Bellomo R, Morimatsu M, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, Gibney N, Tolwani A, Oudemans-van Straaten HM, Ronco C, Kellum JA (2009) Timing of renal replacement therapy and clinical outcomes in critically ill patients with severe acute kidney injury. J Crit Care 24:129–140
Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P and the ADQI workgroup (2004) Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs. Crit Care 8:R204-R212
Bellomo R, Cass A, Cole L, Finfer S, Gallagher M, Lo S, McArthur C, McGuinness S, Myburgh J, Norton R, Scheinkestel C, Su S (2009) Intensity of continuous renal-replacement therapy in critically ill patients. N Engl J Med 361:1627–1638
Brater DC (1998) Diuretic therapy. N Engl J Med 339:387–395
Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, Ragaller M, Weiler N, Moerer O, Gruendling M, Oppert M, Grond S, OlthoffD, Jaschinski U, John S, Roissant R, Welte T, Schaefer M, Kern P, Kuhnt E, Kiehntopf M, Hartog C, Natanson C, Loeffler M, Reinhardt K (2008) Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 358:125–139
Cole L, Bellomo R, Hart G, Journois D, Davenport P, Tipping P, Ronco C (2002) A phase II randomized, controlled trial of continuous hemofiltration in sepsis. Crit Care Med 30:100–106
Cox CD, Tsikouris JD (2004) Preventing contrast nephropathy: What ist the best strategy? J Clin Pharmacol 44:327–337
Druml W (1999) Metabolic aspects of continuous renal replacement therapies. Kidney Int 56:S56-S61
Fliser D, Kielstein JT (2004) A single-pass batch dialysis system: an ideal dialysis method for the patient in intensive care with acute renal failure. Curr Opin Crit Care 10:483–488
Friedrich JO, Adhikari N, Herridge MS, Beyene J (2005) Metaanalysis: Low-dose dopamine increases urine output but does not prevent renal dysfunction or death. Ann Intern Med 142:510–524
Gabriel A, Müller E, Tarnow J (2001) Therapie des akuten Nierenversagens - Konzepte und Kontroversen (Teil I - Pharmakologische Behandlung und experimentelle Therapieansätze). Anästhesiol Intensivmed Notfallmed Schmerzther 36:134–142
Gabriel A, Müller E, Tarnow J (2001) Therapie des akuten Nierenversagens - Konzepte und Kontroversen (Teil II - Extrakorporale Nierenersatzverfahren und Peritonealdialyse). Anästhesiol Intensivmed Notfallmed Schmerzther 36:195–204
Ho KM, Sheridan DJ (2006) Meta-analysis of frusemide to prevent or treat acute renal failure. BMJ 333:420–426
Jakob SM (2004) Prevention of acute renal failure - fluid repletion and colloids. Int J Artif Organs 27:1043–1048
Joannidis M, Metnitz B, Bauer P, Schusterschitz N, Moreno R, Druml W, Metnitz PG (2009) Acute kidney injury in critically ill patients classified by AKIN versus RIFLE using the SAPS 3 database. Intensive Care Med 35:1692–1702
Keller E (1995) Einfluß der kontinuierlichen Nierenersatztherapie auf die Pharmakokinetik von Arzneimitteln. Anästhesiologie und Intensivmedizin 36:300–306
Kellum Ja, Decker J (2001) Use of dopamine in acute renal failure: a meta-analysis. Crit Care Med 29:1526–1531
Kelly AM, Dwamena B, Cronin P, Bernstein SJ, Carlos RC (2008) Meta-analysis: Effectiveness of drugs for preventing contrastinduced nephropathy. Ann Int Med 148:284–294
Lameire NH, De Vriese AS, Vanholder R (2003) Prevention and nondialytic treatment of acute renal failure. Curr Opin Crit Care 9:481–490
Levy EM, Viscoli CM, Horwitz RI (1996) The effect of acute renal failure on mortality. JAMA 275:1489–1494
Lin SM, Huang CD, Lin HC, Liu CY, Wang CH, Kuo HP (2006) A modified goal-directed protocol improves clinical outcomes in intensive care unit patients with septic shock: a randomized controlled trial. Shock 26:551–557
Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, Levin A (2007) Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 11:R31-R38
Meier P, Ko DT, Tamura A, Tamhane U, Gurm HS (2009) Sodium bicarbonate-based hydration prevents contrast-induced nephropathy: a meta-analysis. BMJ 7:23
Merten GJ, Burgess WP, Gray LV, Hollemann JH, Roush TS, Kowalchuk GJ, Bersin RM, van Moore A, Simonton CA, Rittase RA, Norton HJ, Kennedy TP (2004) Prevention of contrast-induced nephropathy with sodium bicarbonate. JAMA 291:2328–2334
Metnitz PG, Krenn CG, Steltzer H, Lang T, Ploder J, Lenz K, Le Gall JR, Druml W (2002) Effect of acute renal failure requiring renal replacement therapy on outcome in critically ill patients. Crit Care Med 30:2051–2058
Morath C, Miftari N, Dikow R, Hainer C, Zeier M, Schwenger V, Weigand MA (2006) Nierenersatztherapie auf der Intensivstation. Anästhesist 55:901–914
Oppert M, Engel C, Brunkhorst FM, Bogatsch H, Reinhardt K, Frei U, Eckhardt KU, Loeffler M, John S (2008) Acute renal failure in patients with severe sepsis and septic shock - a significant independent risk factor for mortality: results from the German prevalence study. Nephrol Dial Transplant 23:904–909
Oudemans-van Straaten H, Bosman RJ, Koopmans M, Van Der Voort PH, Wester JP, Van Der Spoel JI, Dijksman LM, Zandstra DF (2009) Citrate anticoagulation for continuous venovenous hemofiltration. Crit Care Med 37:545–552
Palevsky PM (2008) Indications and timing of renal replacement therapy in acute kidney injury. Crit Care Med 33 (Suppl):S224-S228
Palevsky PM, Zhang JH, O´Connor TZ, Chertow GM, Crowley ST, Choudhury D, Finkel K, Kellum JA, Paganini E, Schein RM, Smith MW, Swanson KM, Thompson BT, Vijayan A, Watnick S, Star RA, Peduzzi P (2008) Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med 359:7–20
Pannu N, Manns B, Lee H, Tonelli M (2004) Systematic review of the impact of N-acetylcysteine on contrast nephropathy. Kidney Int 65:1366–1374
Payen D, de Pont AC, Sakr Y, Spies C, Reinhart K, Vincent JL (2008) A positive fluid balance is associated with a worse outcome in patients with acute renal failure. Crit Care 12:R74
Ragaller MJR, Theilen H, Koch T (2001) Volume replacement in critically ill patients with acute renal failure. J Am Soc Nephrol 12:S33-S39
Redl-Wenzl EM, Armbruster C, Edelmann G, Fischl E, Kolacny M, Wechsler-Fördös A, Sporn P (1993) The effects of norepinephrine on hemodynamics and renal function in severe septic shock states. Intensive Care Med 19:151–154
Ricci Z, Cruz D, Ronco C (2008) The RIFLE criteria and mortality in acute kidney injury: A systemic review. Kidney International 73:538–546
Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A,, Knoblich B, Peterson E, Tomlanovich M (2001) Early goal directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345:1368–1377
Ronco C, Bellomo R, Homel P, Brendolan A, Dan M, Piccinni P, La Greca G (2000) Effects of different doses in continuous venovenous haemofiltration on outcomes of acute renal failure: a prospective randomised trial. Lancet 355:26–30
Schabinski F, Oishi J, Tuche F, Luy A, Sakr Y, Bredle D, Hartog C, Reinhart K (2009) Effects of a predominantly hydroxyethyl starch (HES)-based and a predominantly non HES-based fluid therapy on renal function in surgical ICU patients. Intensive Care Med 35:1539–1547
Schiffl H, Lang SM, Fischer R (2002) Daily hemodialysis and the outcome of acute renal failure. N Engl J Med 346:305–310
Seabra VF, Balk EM, Liangos O, Sosa MA, Cendoroglo M, Jaber BL (2008) Timing of renal replacement therapy in acute renal failure: A meta-analysis. Am J Kidney Dis 52:272–284
Segal JM, Phang PT, Walley KR (1992) Low-dose dopamine hastens onset of gut ischemia in a porcine model of hemorrhagic shock. J Appl Physiol 73:1159–1164
Simon S, Stille W (2000) Antibiotikatherapie in Klinik und Praxis. Schattauer, Stuttgart New York
Singer I, Epstein M (1998) Potential of dopamine A-1 agonists in the management of acute renal failure. Am J Kidney Dis 31:743–755
Swartz RD, Messana JM, Orzol S, Port FK (1999) Comparing continuous hemofiltration with hemodialysis in patients with severe acute renal failure. Am J Kidney Dis 34:424–432
Tepel M, Van Der Giet M, Schwarzfeld C, Laufer U, Liermann D, Zidek W (2000) Prevention of radiographic-contrast-agentinduced reductions in renal function by acetylcysteine. N Engl J Med 343:180–184
Townsend DR, Bagshaw SM (2008) New insights on intravenous fluids, diuretics and acute kidney injury. Nephron Clin Pract 109:c206-c216
Uchino S, Kellum JA, Bellomo R, Doig GS, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, Gibney N, Tolwani A, Ronco C (2005) Acute renal failure in critically ill patients - a multinational, multicenter study. JAMA 294:813–818
Uehlinger DE, Jakob SM, Ferrari P, Eichelberger M, Huynh-Do U, Marti HP, Mohaupt MG, Vogt B, Rothen HU, Regli B, Takala J, Frey FJ (2005) Comparison of continous and intermittent renal replacement therapy for acute renal failure. Nephrol Dial Transplant 20:1630–1637
Van Den Berghe G, de Zegher F (1996) Anterior pituitary function during critical illness and dopamine treatment. Crit Care Med 25:1580–1590
Vivino G, Antonelli M, Moro ML, Cottini F, Conti G, Bufi M, Cannata F, Gasparetto A (1998) Risk factors for acute renal failure in trauma patients. Intensive Care Med 24:808–814
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Sydow, K. (2012). Akutes Nierenversagen und Nierenersatztherapie. In: Schwab, S., Schellinger, P., Werner, C., Unterberg, A., Hacke, W. (eds) NeuroIntensiv. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-16911-3_16
Download citation
DOI: https://doi.org/10.1007/978-3-642-16911-3_16
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-16910-6
Online ISBN: 978-3-642-16911-3
eBook Packages: Medicine (German Language)